|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-9-20
|
|
pubmed:abstractText |
Approximately 20% of patients who have hepatoblastoma (HB) still have unresectable disease after preoperative chemotherapy (POC). In these circumstances, orthotopic liver transplantation (OLT) should be performed 1 month after POC. The authors sought to identify presenting features that would predict unresectability in patients with HB and to provide suggestions for early referral and listing for OLT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1050-8
|
|
pubmed:dateRevised |
2007-10-20
|
|
pubmed:meshHeading |
pubmed-meshheading:17661341-Adolescent,
pubmed-meshheading:17661341-Adult,
pubmed-meshheading:17661341-Child,
pubmed-meshheading:17661341-Child, Preschool,
pubmed-meshheading:17661341-Combined Modality Therapy,
pubmed-meshheading:17661341-Female,
pubmed-meshheading:17661341-Follow-Up Studies,
pubmed-meshheading:17661341-Hepatoblastoma,
pubmed-meshheading:17661341-Humans,
pubmed-meshheading:17661341-Infant,
pubmed-meshheading:17661341-Liver Neoplasms,
pubmed-meshheading:17661341-Liver Transplantation,
pubmed-meshheading:17661341-Male,
pubmed-meshheading:17661341-Prognosis,
pubmed-meshheading:17661341-Retrospective Studies,
pubmed-meshheading:17661341-Survival Analysis,
pubmed-meshheading:17661341-Treatment Outcome,
pubmed-meshheading:17661341-alpha-Fetoproteins
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Features predicting unresectability in hepatoblastoma.
|
|
pubmed:affiliation |
Department of Pediatrics, University of Padova, Padova, Italy. lorenzo.dantiga@pediatria.unipd.it
|
|
pubmed:publicationType |
Journal Article
|
